The Atlanta Braves couldn’t have asked for a much better start to the second half of the season.
Fresh off the All-Star break, Atlanta overwhelmed the Texas Rangers with a dominant 15-1 victory, collecting 19 hits while Chris Sale delivered another vintage performance on the mound. The win reinforced why the Braves remain one of the National League’s top contenders as they continue to battle atop the NL East.
But even after the lopsided victory, one storyline continues to loom over Atlanta’s postseason aspirations.
The Braves know their championship hopes may ultimately depend less on their explosive offense and more on whether two of their most talented starting pitchers can return before October.
Unfortunately, the latest update wasn’t exactly encouraging.
Prior to the Rangers series, manager Walt Weiss offered a sobering assessment of injured right-handers Spencer Schwellenbach and Spencer Strider, making it clear that neither pitcher is close to returning. Weiss indicated there is currently no firm timetable for either hurler, and their availability for the remainder of the season remains uncertain.
That news comes as a significant blow for a Braves club that has spent much of the season overcoming adversity in its starting rotation.
Schwellenbach entered 2026 with enormous expectations after emerging as one of baseball’s brightest young pitchers. During his impressive rookie campaign, he posted a 2.42 ERA in seven starts, and he followed that by developing into one of Atlanta’s most dependable rotation pieces before elbow issues interrupted his momentum. His 2026 season never truly got underway after undergoing elbow surgery in February to remove bone spurs, an operation that immediately landed him on the 60-day injured list.
For months, optimism surrounded the possibility that Schwellenbach could return sometime during the second half.
There had even been speculation that he might begin a rehabilitation assignment around the All-Star break. That has yet to happen, however, and every passing day narrows the window for him to build enough innings before the postseason. Even if a rehab assignment begins soon, he would still likely need several weeks before being fully stretched out for major league competition.
The outlook surrounding Strider is equally concerning.
The former All-Star opened the season on the injured list with an oblique strain before later returning to the rotation, only to be sidelined again after developing elbow inflammation. While the Braves have not officially ruled him out for the year, Weiss acknowledged there is no clear timetable for his return, leaving considerable uncertainty surrounding one of the game’s premier strikeout pitchers.
Losing either pitcher would be difficult.
Potentially missing both for most—or all—of the stretch run dramatically changes Atlanta’s outlook.
Fortunately for the Braves, several members of the rotation have stepped forward.
Chris Sale continues to perform like one of baseball’s elite starters. His dominance against Texas was another reminder that he remains capable of leading a postseason rotation, while the Braves have also received valuable contributions from the rest of their pitching staff throughout the summer. Atlanta’s ability to stay atop the division despite multiple injuries speaks volumes about the club’s depth and resilience.
Still, October baseball often comes down to frontline pitching.
A healthy rotation featuring Sale, Schwellenbach, and Strider would give Atlanta one of the most formidable playoff staffs in the National League. Without the latter two, the Braves may need to rely far more heavily on their bullpen and back-end starters against elite postseason opponents.
That reality also places added pressure on the front office.
With the trade deadline rapidly approaching, Atlanta could find itself exploring the pitching market more aggressively if it becomes clear that Schwellenbach and Strider won’t return in time to make meaningful contributions. Recent reports have already suggested that uncertainty surrounding the rotation has increased the urgency for the Braves to evaluate external options before Aug. 3.
For now, though, patience remains the only option.
The Braves continue to win games, remain in first place, and boast one of the National League’s deepest rosters. Yet every series that passes without progress from two key members of the rotation increases the importance of finding reinforcements elsewhere.
Atlanta has proven it can survive adversity.
Whether it can sustain a World Series run may ultimately depend on whether two of its most important pitchers can make it back to the mound before time runs out.